147 related articles for article (PubMed ID: 5620801)
1. [Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
Melani F; Lawecki J; Bartelt KM; Pfeiffer EF
Diabetologia; 1967 Oct; 3(5):422-6. PubMed ID: 5620801
[No Abstract] [Full Text] [Related]
2. Insulin response to glucagon with or without tolbutamide in normal and diabetic subjects.
Chiba M; Ohneda A; Sakai T; Goto Y
Tohoku J Exp Med; 1982 Feb; 136(2):169-75. PubMed ID: 7041329
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-induced insulin secretion in normal diabetic subjects.
Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
[TBL] [Abstract][Full Text] [Related]
4. [Plasma insulin levels in endocrine diseases. I. Plasma insulin levels in normal subjects and diabetic patients].
Ikeda M
Nihon Naibunpi Gakkai Zasshi; 1971 Aug; 47(5):282-90. PubMed ID: 5106320
[No Abstract] [Full Text] [Related]
5. [The behaviour of the serum insulin level in non obese adult diabetics after intravenous glucose, tolbutamide and glucagon].
Lawecki J; Rogala H; Czyzyk A; Kowalski H
Acta Diabetol Lat; 1970; 7(3):407-20. PubMed ID: 5515384
[No Abstract] [Full Text] [Related]
6. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.
Perley M; Kipnis DM
Diabetes; 1966 Dec; 15(12):867-74. PubMed ID: 5957477
[No Abstract] [Full Text] [Related]
7. I.R.I. after glucagon administration in groups of obese subjects, with no family history of diabetes, with normal glucose tolerance test, with chemical diabetes, or with mild not ketotic diabetes mellitus.
Adezati L; Prando R; Cristofolini MP; Pagliaini R
Acta Isot (Padova); 1970; 10(3):319-32. PubMed ID: 5003714
[No Abstract] [Full Text] [Related]
8. [Serum immunoreactive insulin in clinical practice].
Foà PP
Acta Diabetol Lat; 1971; 8(5):975-90. PubMed ID: 5138195
[No Abstract] [Full Text] [Related]
9. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
Bagdade JD; Bierman EL; Porte D
Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
[No Abstract] [Full Text] [Related]
10. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
Castells S; Avruskin T; Reddy CM; Hashemi SE
Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938
[TBL] [Abstract][Full Text] [Related]
11. Improvement in insulin secretion in diabetes after diazoxide.
Greenwood RH; Mahler RF; Hales CN
Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
[TBL] [Abstract][Full Text] [Related]
12. [Estimation of insulin efficacy in obesity by the response of blood insulin and glucose to intravenous tolbutamide].
Vague P; Depieds R; Boeuf G; Leroy C; Perrimond D; Codaccioni JL; Vague J
Ann Endocrinol (Paris); 1966; 27(6):820-9. PubMed ID: 5973133
[No Abstract] [Full Text] [Related]
13. Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man.
Ryan WG; Nibbe AF; Schwartz TB
Lancet; 1967 Jun; 1(7502):1255-6. PubMed ID: 4165041
[No Abstract] [Full Text] [Related]
14. Acute insulin response to glucagon, tolbutamide, and glucose in non-insulin-dependent diabetes of the young.
Naidoo C; Jialal I; Suleman A; Rajput MC; Joubert SM
Diabetes Care; 1986; 9(1):57-60. PubMed ID: 3512209
[TBL] [Abstract][Full Text] [Related]
15. [Blood insulin and diabetes. I. Method of study--normal subjects--diabetic disease].
Duprey J; Lubetzki J
Pathol Biol (Paris); 1971 Mar; 19(5):311-31. PubMed ID: 4929994
[No Abstract] [Full Text] [Related]
16. Selective defect in insulin release in one form of spontaneous laboratory diabetes.
Larkins RG; Martin FI
Nat New Biol; 1972 Jan; 235(55):86-8. PubMed ID: 4501348
[No Abstract] [Full Text] [Related]
17. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
[TBL] [Abstract][Full Text] [Related]
18. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
Barnes AJ; Garbien KJ; Crowley MF; Bloom A
Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
[No Abstract] [Full Text] [Related]
19. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
Devrim S; Koniçe M; Sencer E; Molvalìlar S; Alp H
Isr J Med Sci; 1972 Jun; 8(6):815-20. PubMed ID: 5051802
[No Abstract] [Full Text] [Related]
20. [Critical considerations regarding the obesity-hyperinsulinism concept].
Melani F
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():332-40. PubMed ID: 4907222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
